The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

A failed clinical study has not closed the door on using GLP-1 drugs to treat vascular dementia. Researchers say the science ...

Some widely prescribed drugs may quietly affect your memory, focus, and cognitive performance. Here’s how they work, who’s ...

A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type 2 diabetes. Reading time 2 minutes The case for Ozempic as a dementia ...

Scientists hope to investigate whether common drugs could be used to help fight dementia after ibuprofen and some prescription antibiotics, antivirals and vaccines were associated with a reduced risk ...

GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for ...

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...

A groundbreaking analysis from leading British universities has uncovered surprising links between everyday medications and dementia prevention, offering fresh hope in the fight against cognitive ...

A groundbreaking development in diabetes treatment reveals that SGLT-2 inhibitors significantly reduce dementia risk among type 2 diabetes patients. Recent research demonstrates these medications ...

Dr. Scott Turner does his best to treat patients with memory disorders such as dementia. While there are treatments that may temporarily help, there's no cure for dementia, which is why a new study is ...

Semaglutide, the drug behind weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline among people with ...

On its own, LATE dementia is less severe than Alzheimer’s, but in combination, it makes Alzheimer’s symptoms worse, ...